Barclays PLC Horizon Therapeutics Public LTD CO Transaction History

Barclays PLC

  • $327 Billion
  • Q2 2024

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023
SELL
$98.98 - $115.74 $27.7 Million - $32.4 Million
-279,641 Reduced 28.56%
699,553 $80.9 Million
Q2 2023

Aug 03, 2023
SELL
$96.34 - $112.38 $54.7 Million - $63.8 Million
-568,050 Reduced 36.71%
979,194 $101 Million
Q1 2023

May 04, 2023
BUY
$107.32 - $113.5 $84.7 Million - $89.6 Million
789,395 Added 104.16%
1,547,244 $169 Million
Q4 2022

Feb 13, 2023
SELL
$62.39 - $113.8 $193 Million - $352 Million
-3,094,447 Reduced 80.33%
757,849 $86.2 Million
Q3 2022

Nov 03, 2022
BUY
$58.92 - $84.67 $210 Million - $302 Million
3,563,851 Added 1235.54%
3,852,296 $238 Million
Q2 2022

Aug 12, 2022
SELL
$79.4 - $116.36 $22.8 Million - $33.5 Million
-287,728 Reduced 49.94%
288,445 $23 Million
Q1 2022

May 16, 2022
BUY
$86.42 - $109.81 $36.2 Million - $46 Million
419,265 Added 267.2%
576,173 $60.6 Million
Q4 2021

Feb 14, 2022
SELL
$98.56 - $119.91 $3.49 Million - $4.24 Million
-35,363 Reduced 18.39%
156,908 $16.9 Million
Q3 2021

Nov 09, 2021
SELL
$91.91 - $110.37 $1.55 Million - $1.86 Million
-16,851 Reduced 8.06%
192,271 $21.1 Million
Q2 2021

Aug 13, 2021
BUY
$86.24 - $95.92 $3.56 Million - $3.96 Million
41,309 Added 24.62%
209,122 $19.6 Million
Q1 2021

May 13, 2021
BUY
$71.83 - $95.48 $5.18 Million - $6.88 Million
72,095 Added 75.32%
167,813 $15.4 Million
Q4 2020

Feb 11, 2021
BUY
$67.0 - $84.39 $6.1 Million - $7.69 Million
91,095 Added 1970.47%
95,718 $7 Million
Q3 2020

Nov 12, 2020
SELL
$55.23 - $79.93 $190,764 - $276,078
-3,454 Reduced 42.76%
4,623 $359,000
Q2 2020

Aug 12, 2020
SELL
$30.2 - $56.98 $44,182 - $83,361
-1,463 Reduced 15.34%
8,077 $449,000
Q1 2020

May 13, 2020
SELL
$24.87 - $38.56 $440,671 - $683,244
-17,719 Reduced 65.0%
9,540 $282,000
Q4 2019

Feb 10, 2020
SELL
$25.43 - $36.67 $3.65 Million - $5.26 Million
-143,389 Reduced 84.03%
27,259 $987,000
Q3 2019

Nov 14, 2019
SELL
$23.0 - $27.97 $5.44 Million - $6.61 Million
-236,309 Reduced 58.07%
170,648 $4.65 Million
Q2 2019

Aug 14, 2019
BUY
$22.81 - $28.48 $9.28 Million - $11.6 Million
406,957 New
406,957 $9.79 Million

Others Institutions Holding HZNP

# of Institutions
39
Shares Held
2.07M
Call Options Held
0
Put Options Held
20K
View Full List

About Horizon Therapeutics Public Ltd Co

HZNP Quotes by TradingView
  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email